Drug Topics
MARCH 5, 2025
Researchers investigated the acceptability of community pharmacy-led influenza vaccination and patients willingness to return for future immunization.
STAT
MARCH 5, 2025
Novo Nordisk will start selling its obesity drug Wegovy directly to patients at a reduced price, following a similar move from Eli Lilly as the two drugmakers compete for market share and try to draw patients away from compounding pharmacies that have been making cheaper copies of weight loss drugs. Wegovy normally carries a list price of about $1,350 a month, but Novo will sell the treatment through its new direct-to-consumer offering called NovoCare Pharmacy at $499 a month for all doses to ca
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
MARCH 5, 2025
Researchers analyzed the association between adherence to a Mediterranean diet and obesity cancers, with a focus on the mediating role adiposity plays throughout the process.
STAT
MARCH 5, 2025
Jazz Pharmaceuticals said Wednesday it would spend nearly $1 billion to buy Chimerix and its experimental pill for a devastating brain tumor that primarily affects children and young adults. The tumor, known as diffuse midline glioma, or DMG (and sometimes as DIPG depending on where it’s found), has flummoxed researchers for decades. It often wraps itself around a patient’s brain stem, preventing surgeons from safely excising it.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
MARCH 5, 2025
Investigators found that zonisamide was associated with a reduction in monthly migraine days for pediatric populations.
STAT
MARCH 5, 2025
Y ou’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine. Sign up to get it delivered in your inbox every Wednesday. I’m here at the Healthcare Information and Management Systems Society conference in Las Vegas. So far I’ve eaten a subpar casino restaurant won ton soup, seen the “Postcard from Earth” show at Sphere, and talked to a lot of pe
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
PharmaVoice
MARCH 5, 2025
The company's vice president and general manager of U.S. business operations explains how Amgen is going to deliver on its “ambitious growth aspirations.
Drug Topics
MARCH 5, 2025
In a third installment of our interview series with Chris Robinson, MD, PhD, we looked at the future of pain management and emerging technologies being used for treatment.
Pharma Marketing Network
MARCH 5, 2025
Introduction In the highly regulated world of pharmaceutical marketing , mastering Google Ads management can be a game-changer. With millions of healthcare professionals (HCPs) and patients turning to Google for medical information, paid search ads present a huge opportunity for pharma brands to boost engagement and conversions. However, the landscape isnt simple.
Drug Topics
MARCH 5, 2025
The main motivations for preferring vaccination included previous experience with an RSV infection and desire to protect the baby.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Hospital Pharmacy Europe
MARCH 5, 2025
More than half of patients are unsure when their asthma inhaler is empty, with some continuing to use the device when it is empty with serious implications for managing their condition, research has shown. A study measured the amount of medicine left in more than 2,600 pressurised metered-dose inhalers that had been returned for recycling and found many were returned under or overused.
Drug Topics
MARCH 5, 2025
All dosages of semaglutide (Wegovy) under the new program will be available at $499 per month for patients that are uninsured or who do not have coverage for obesity medication.
Fierce Healthcare
MARCH 5, 2025
More than a dozen medical products and services would be covered through high-deductible health plans if an approved House bill is passed by the Senate.
Pharma Marketing Network
MARCH 5, 2025
Introduction Pharmaceutical marketing has changed. Traditional outreach methods are no longer enough to engage healthcare professionals (HCPs) and patients in a digital-first world. Thats where PPC advertising strategies come into play. But heres the challenge pharma PPC isnt like other industries. Regulatory restrictions, compliance concerns, and complex audience targeting make it one of the toughest sectors to master in digital advertising.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
PharmaVoice
MARCH 5, 2025
A licensing deal with Denmark’s Gubra gives the immunology giant control of an experimental therapy that could compete with drugs from Novo Nordisk, Eli Lilly and Zealand.
Med Ed 101
MARCH 5, 2025
JD is a 58-year-old male with a history of cirrhosis due to alcohol-related liver disease. He has no medication allergies and is taking the following medications: Lactulose 30 mL twice daily, Spironolactone 100 mg daily, Furosemide 40 mg daily, Propranolol 20 mg twice daily JD presents to the clinic with complaints of frequent loose stools, […] The post Deprescribing in Cirrhosis – Case Study appeared first on Med Ed 101.
Pharmacy Times
MARCH 5, 2025
Adalimumab biosimilars differ from adalimumab in approved indications, concentration and dosage, and formulation.
pharmaphorum
MARCH 5, 2025
The FDA has approved the first generic versions of Johnson & Johnson's big-selling anticoagulant Xarelto
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
MARCH 5, 2025
Unlike other professionals such as nurses and physicians, pharmacists remain tethered to a fragmented state-by-state licensure model that creates unnecessary barriers to care.
Fierce Healthcare
MARCH 5, 2025
Dozens of providers have filed new lawsuits against Blues insurers, arguing that the plans colluded to block competition and reimburse them at lower rates.
pharmaphorum
MARCH 5, 2025
FDA starts a review of Roche's Gazyva as a treatment for lupus nephritis, an indication that analysts think could unlock renewed sales growth
Fierce Healthcare
MARCH 5, 2025
A federal court has signed off on a $700 million class action settlement that will see drug manufacturers and distributors pay more than 1,000 acute care hospitals over alleged misconduct regarding | Prescription opioid manufacturers and distributors agreed to pay hundreds of millions to a class of more than 1,000 acute care hospitals.
Pharmacy Times
MARCH 5, 2025
Dogs share a number of cancers with humans, including melanoma, non-Hodgkin lymphoma, leukemia, and osteosarcoma.
Fierce Healthcare
MARCH 5, 2025
Digital health venture capital funding cooled off in 2024 following the fever pitch of investment from 2020 to 2022. But investors still see bright opportunities for the sector.
Pharmacy Times
MARCH 5, 2025
Following allogeneic hematopoietic stem cell transplantation (allo-HSCT), luspatercept effectively improved signs of anemia in patients with a variety of hematologic conditions.
Fierce Healthcare
MARCH 5, 2025
The U.S. Navy has tapped Headspace to provide active duty military personnel with access to app-based mental health coaching. | The United States Navy has tapped Headspace to provide active duty military personnel with access to app-based mental health coaching.
Pharmacy Times
MARCH 5, 2025
Pharmacists have been central to vaccine distribution since the COVID-19 pandemic, and as viruses spread, they must continue urging patients to stay updated on vaccinations to prevent severe illness and reduce hospitalizations.
pharmaphorum
MARCH 5, 2025
Things will get tougher before they get better at Bayer, according to CEO Bill Anderson, as the group reports its 2024 financial results.
Pharmacy Times
MARCH 5, 2025
Tezepelumab demonstrated efficacy compared with placebo when treating patients with chronic rhinosinusitis with nasal polyps.
Fierce Healthcare
MARCH 5, 2025
Baxter International developed a voice-activated, hands-free technology to make it easier for nurses and medical professionals to do their jobs on a busy hospital floor.
Pharmaceutical Technology
MARCH 5, 2025
The 25% US tariffs on Canada and Mexico have put into question a three-decade-long free trade agreement in North America.
pharmaphorum
MARCH 5, 2025
Jazz has reached an agreement to buy Chimerix for around $935 million, adding a brain cancer drug heading for an FDA approval decision in August.
Pharmaceutical Technology
MARCH 5, 2025
The acquisition will give Jazz access to Chimerixs lead investigational candidate dordaviprone.
Expert insights. Personalized for you.
346 
Let's personalize your content